Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits

T. Fukumoto, Akihiro Matsukawa, S. Ohkawara, K. Takagi, M. Yoshinaga

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Endogenous IL-1 receptor antagonist (IL-1ra) may down-regulate part of IL-1 actions. We examined the participation of endogenous IL-1ra in the production of IL-1β in vitro. Macrophages cultured on adherent IgG produced a 100-fold molar excess of IL-1ra, compared with IL-1β. In the presence of a neutralizing monoclonal antibody (mAb) against rabbit IL-1ra, the production of antigenic IL-1β increased by 20-60%. Since the molar ratio of IL-1ra over IL-1 was 160- to 400-fold in synovial fluid (SF) of lipopolysaccharide (LPS)-induced arthritis, we examined the functional role of endogenous IL-1ra in the regulation of inflammatory responses. When measured in the presence of anti-IL-1ra mAb, masked IL-1 activity in SF became evident, with a 3- to 4-fold increment. The administration of anti-IL-1ra mAb with LPS into rabbit knee joints increased the IL-1 activity 4-fold and the production of antigenic IL-1β by 30-50%. The treatment also enhanced by 20-40% LPS-induced leukocyte infiltration and protein leakage. Therefore, endogenous IL-1ra apparently acts as a down-regulating factor for limiting deleterious effects of IL-1 by masking the biological activity and by inhibiting the production.

Original languageEnglish
Pages (from-to)479-485
Number of pages7
JournalInflammation Research
Volume45
Issue number9
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Interleukin-1 Receptors
Neutralizing Antibodies
Interleukin-1
Arthritis
Lipopolysaccharides
Rabbits
Synovial Fluid
Monoclonal Antibodies
Fluids
Macrophages
Knee Joint
Bioactivity
Infiltration
Leukocytes
Down-Regulation
Immunoglobulin G

Keywords

  • Anti-IL-1ra monoclonal antibody
  • IL-1
  • IL-1 receptor antagonist
  • Lipopolysaccharide-induced arthritis

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology (medical)
  • Immunology
  • Cell Biology

Cite this

Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits. / Fukumoto, T.; Matsukawa, Akihiro; Ohkawara, S.; Takagi, K.; Yoshinaga, M.

In: Inflammation Research, Vol. 45, No. 9, 1996, p. 479-485.

Research output: Contribution to journalArticle

@article{d04459de47654180be3de03206130a61,
title = "Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits",
abstract = "Endogenous IL-1 receptor antagonist (IL-1ra) may down-regulate part of IL-1 actions. We examined the participation of endogenous IL-1ra in the production of IL-1β in vitro. Macrophages cultured on adherent IgG produced a 100-fold molar excess of IL-1ra, compared with IL-1β. In the presence of a neutralizing monoclonal antibody (mAb) against rabbit IL-1ra, the production of antigenic IL-1β increased by 20-60{\%}. Since the molar ratio of IL-1ra over IL-1 was 160- to 400-fold in synovial fluid (SF) of lipopolysaccharide (LPS)-induced arthritis, we examined the functional role of endogenous IL-1ra in the regulation of inflammatory responses. When measured in the presence of anti-IL-1ra mAb, masked IL-1 activity in SF became evident, with a 3- to 4-fold increment. The administration of anti-IL-1ra mAb with LPS into rabbit knee joints increased the IL-1 activity 4-fold and the production of antigenic IL-1β by 30-50{\%}. The treatment also enhanced by 20-40{\%} LPS-induced leukocyte infiltration and protein leakage. Therefore, endogenous IL-1ra apparently acts as a down-regulating factor for limiting deleterious effects of IL-1 by masking the biological activity and by inhibiting the production.",
keywords = "Anti-IL-1ra monoclonal antibody, IL-1, IL-1 receptor antagonist, Lipopolysaccharide-induced arthritis",
author = "T. Fukumoto and Akihiro Matsukawa and S. Ohkawara and K. Takagi and M. Yoshinaga",
year = "1996",
language = "English",
volume = "45",
pages = "479--485",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Birkhauser Verlag Basel",
number = "9",

}

TY - JOUR

T1 - Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits

AU - Fukumoto, T.

AU - Matsukawa, Akihiro

AU - Ohkawara, S.

AU - Takagi, K.

AU - Yoshinaga, M.

PY - 1996

Y1 - 1996

N2 - Endogenous IL-1 receptor antagonist (IL-1ra) may down-regulate part of IL-1 actions. We examined the participation of endogenous IL-1ra in the production of IL-1β in vitro. Macrophages cultured on adherent IgG produced a 100-fold molar excess of IL-1ra, compared with IL-1β. In the presence of a neutralizing monoclonal antibody (mAb) against rabbit IL-1ra, the production of antigenic IL-1β increased by 20-60%. Since the molar ratio of IL-1ra over IL-1 was 160- to 400-fold in synovial fluid (SF) of lipopolysaccharide (LPS)-induced arthritis, we examined the functional role of endogenous IL-1ra in the regulation of inflammatory responses. When measured in the presence of anti-IL-1ra mAb, masked IL-1 activity in SF became evident, with a 3- to 4-fold increment. The administration of anti-IL-1ra mAb with LPS into rabbit knee joints increased the IL-1 activity 4-fold and the production of antigenic IL-1β by 30-50%. The treatment also enhanced by 20-40% LPS-induced leukocyte infiltration and protein leakage. Therefore, endogenous IL-1ra apparently acts as a down-regulating factor for limiting deleterious effects of IL-1 by masking the biological activity and by inhibiting the production.

AB - Endogenous IL-1 receptor antagonist (IL-1ra) may down-regulate part of IL-1 actions. We examined the participation of endogenous IL-1ra in the production of IL-1β in vitro. Macrophages cultured on adherent IgG produced a 100-fold molar excess of IL-1ra, compared with IL-1β. In the presence of a neutralizing monoclonal antibody (mAb) against rabbit IL-1ra, the production of antigenic IL-1β increased by 20-60%. Since the molar ratio of IL-1ra over IL-1 was 160- to 400-fold in synovial fluid (SF) of lipopolysaccharide (LPS)-induced arthritis, we examined the functional role of endogenous IL-1ra in the regulation of inflammatory responses. When measured in the presence of anti-IL-1ra mAb, masked IL-1 activity in SF became evident, with a 3- to 4-fold increment. The administration of anti-IL-1ra mAb with LPS into rabbit knee joints increased the IL-1 activity 4-fold and the production of antigenic IL-1β by 30-50%. The treatment also enhanced by 20-40% LPS-induced leukocyte infiltration and protein leakage. Therefore, endogenous IL-1ra apparently acts as a down-regulating factor for limiting deleterious effects of IL-1 by masking the biological activity and by inhibiting the production.

KW - Anti-IL-1ra monoclonal antibody

KW - IL-1

KW - IL-1 receptor antagonist

KW - Lipopolysaccharide-induced arthritis

UR - http://www.scopus.com/inward/record.url?scp=0029795485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029795485&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 479

EP - 485

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 9

ER -